Treating aids and HIV infection with methionine
March 2, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesFortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters Method of treatment of rheumatoid arthritis Composition and process for promoting epithelial regeneration Apparatus and process for cooling a plasma arc electrode Antioxidant compositions and methods for ameliorating inflammatory symptoms of respiratory disease Treating inflammatory pain with methionine Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds Patent #: 5084482 InventorsApplicationNo. 845157 filed on 03/02/1992US Classes:514/554, Amine addition salt of the acid514/561, Nitrogen other than as nitro or nitroso nonionically bonded514/562, Sulfur nonionically bonded514/579Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAIExaminersPrimary: Nutter, Nathan M.Foreign Patent References
International ClassesA01N 037/30A01N 037/12 A01N 037/44 A61K 031/13 AbstractThis invention concerns novel safe compositions containing as an active antioxidant or antiinflammatory agent and thiol-repleting agent, the amino acid methionine, and/or one or more related compounds including certain metabolic precursor compounds, and novel methods employing the compositions for treating or amelio-rating symptoms of human immunodeficiency virus infection and AIDS, such as weight loss, increased red cell sedimentation, and leukoplakia; novel methods employing the compositions for treating or inhibiting symptoms resulting from nutritional deficiencies of methionine; and novel methods employing the compositions for inhibiting or preventing triglyceride elevation due to low dose methionine consumption. The compounds include the methionine hydroxy analogs, as well as compounds having the structural formula ##STR1## 1-, dl- or d- form and pharmaceutically acceptable N- (mono- and di-carboxylic acid) acyl derivatives and alkyl esters thereof.Field of SearchAmine addition salt of the acidNitrogen other than as nitro or nitroso nonionically bonded Sulfur nonionically bonded Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI Sulfur, selenium or tellurium compound (e.g., thioalcohols, mercaptans, etc.) | |
